Assuring blood safety and availability: Zika virus, the latest emerging infectious disease battlefront

Transfusion

Volumn 56, Issue 7, 2016, Pages 1669-1672

  Kuehnert, Matthew J ^a   Epstein, Jay S ^b  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BACTERIAL TRANSMISSION; BLOOD DONOR; BLOOD SAFETY; BLOOD TRANSFUSION; CHIKUNGUNYA; DENGUE; EDITORIAL; HEPATITIS B VIRUS; HUMAN; INCUBATION TIME; INFECTION; INFECTION RISK; JAUNDICE; NONHUMAN; ORGAN DONOR; ORGAN TRANSPLANTATION; PHYSICAL EXAMINATION; QUESTIONNAIRE; REGISTER; SCREENING TEST; SEQUENCE ANALYSIS; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; TREPONEMA PALLIDUM; VASCULARIZATION; VIRUS TRANSMISSION; ZIKA FEVER; ZIKA VIRUS;

EID: 84977644381     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13673     Document Type: Editorial

References (11)

1. Perkins HA, Busch MP. Transfusion-associated infections: 50 years of relentless challenges and remarkable progress. Transfusion 2010;50:2080-99.
2. Iwamoto M, Jernigan DB, Guasch A, et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 2003;29:2196-203.
3. Petersen LR, Jamieson DJ, Powers AM, et al. Zika virus. N Engl J Med 2016;374:1552-63.
4. Plourde AR, Bloch EM. A literature review of Zika virus. Emerging Infect Dis J 2016;22: doi: 10.3201/eid2207.151990.
5. Hills SL, Russell K, Hennessey M, et al. Transmission of Zika virus through sexual contact with travelers to areas of ongoing transmission—continental United States, 2016. MMWR Morb Mortal Wkly Rep 2016;65:215-6.
6. Barjas-Castro ML, Cunha M, Suzuki A, et al. Probable transfusion-transmitted Zika virus infection in Brazil. Transfusion 2016;56:1684-88.
7. National Healthcare Safety Network, Biovigilance Component, Hemovigilance Module, Surveillance Protocol [Internet]. Atlanta (GA): Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention. 2016 [cited 2016 Apr 22] Available from: http://www.cdc.gov/nhsn/PDFs/Biovigilance/BV-HV-protocol-current.pdf.
8. AABB Association Bulletin #16-04: Zika, Dengue, and Chikungunya viruses [Internet]. Bethesda (MD): AABB; 2016 [cited 2016 May 20]. Available from: https://www.aabb.org/programs/publications/bulletins/Documents/ab16-04.pdf.
9. Recommendations for donor screening, deferral, and product management to reduce the risk of transfusion-transmission of Zika virus [Internet]. Silver Spring (MD): U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research; 2016 [cited 2016 May 20]. Available from: http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/UCM486360.pdf.
10. Vasquez AM, Sapiano MR, Basavaraju SV, et al. Survey of blood collection centers and implementation of guidance for prevention of transfusion-transmitted Zika virus infection—Puerto Rico, 2016. MMWR Morb Mortal Wkly Rep 2016;65:375-8.
11. Lanteri M, Kleinman S, Glynn S, et al. Zika virus: a new threat to the safety of the blood supply with worldwide impact and implications. Transfusion 2016;56:1907-14.